memantine hydrochloride

Aliphatics - Memantine Hydrochloride is used to treat moderate-to-severe Alzheimer's disease, especially for people who are intolerant of or have a contraindication to AChE inhibitors. It is available as a generic medication. Reference standards of Memantine Hydrochloride API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

stdClass Object
(
    [pname] => Memantine Hydrochloride - Impurity C
    [catalogue_number] => PA 13 15540
    [category_ids] => ,92,82,78,70,
    [chemical_name] => 
    [weight] => 198.73
    [form] => C12H19Cl
    [cas] => 707-36-8
    [pslug] => 707-36-8-memantine-hydrochloride-impurity-c-pa1315540
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)
PA 13 15540
PA 13 15540

Memantine Hydrochloride - Impurity C


  • Catalogue No.:PA 13 15540

  • CAS :

    707-36-8

  • Molecular Formula : C12H19Cl

  • Molecular Weight : 198.73

stdClass Object
(
    [pname] => 1,3,5-Trimethyladamantane
    [catalogue_number] => PA 13 15570
    [category_ids] => ,92,78,70,82,
    [chemical_name] => 
    [weight] => 178.31
    [form] => C13H22
    [cas] => 707-35-7
    [pslug] => 707-35-7-1-3-5-trimethyladamantane-pa1315570
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)
PA 13 15570
PA 13 15570

1,3,5-Trimethyladamantane


  • Catalogue No.:PA 13 15570

  • CAS :

    707-35-7

  • Molecular Formula : C13H22

  • Molecular Weight : 178.31

pharmaffiliates